These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14607952)

  • 21. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
    Kawabata Y; Udono H; Honma K; Ueda M; Mukae H; Kadota J; Kohno S; Yui K
    Infect Immun; 2002 Nov; 70(11):6075-82. PubMed ID: 12379684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers.
    Sedegah M; Belmonte M; Epstein JE; Siegrist CA; Weiss WR; Jones TR; Lu M; Carucci DJ; Hoffman SL
    J Immunol; 2003 Sep; 171(6):3148-53. PubMed ID: 12960342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection.
    Wipasa J; Xu H; Stowers A; Good MF
    J Immunol; 2001 Oct; 167(7):3903-9. PubMed ID: 11564808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.
    Eslava I; Payares G; Pernia BM; Holder AA; Spencer LM
    Malar J; 2010 Feb; 9():46. PubMed ID: 20146804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production, characterisation and immunogenicity of a plant-made Plasmodium antigen--the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1.
    Ma C; Wang L; Webster DE; Campbell AE; Coppel RL
    Appl Microbiol Biotechnol; 2012 Apr; 94(1):151-61. PubMed ID: 22170105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response.
    Hensmann M; Li C; Moss C; Lindo V; Greer F; Watts C; Ogun SA; Holder AA; Langhorne J
    Eur J Immunol; 2004 Mar; 34(3):639-648. PubMed ID: 14991593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and Characterization of Vaccine Candidate Genes Including
    Kim SH; Bae YA; Seoh JY; Yang HJ
    Korean J Parasitol; 2017 Jun; 55(3):255-265. PubMed ID: 28719950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.
    Hirunpetcharat C; Stanisic D; Liu XQ; Vadolas J; Strugnell RA; Lee R; Miller LH; Kaslow DC; Good MF
    Parasite Immunol; 1998 Sep; 20(9):413-20. PubMed ID: 9767608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.
    Miyata T; Harakuni T; Taira T; Matsuzaki G; Arakawa T
    Vaccine; 2012 Jan; 30(5):948-58. PubMed ID: 22119928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam.
    Murhandarwati EE; Wang L; Black CG; Nhan DH; Richie TL; Coppel RL
    Infect Immun; 2009 Oct; 77(10):4510-7. PubMed ID: 19620342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.
    Matsumoto S; Yukitake H; Kanbara H; Yamada H; Kitamura A; Yamada T
    Vaccine; 2000 Nov; 19(7-8):779-87. PubMed ID: 11115699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
    Lozano JM; Lesmes LP; Gallego GM; Patarroyo ME
    Mol Immunol; 2011 Jan; 48(4):657-69. PubMed ID: 21131051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.
    Wipasa J; Xu H; Makobongo M; Gatton M; Stowers A; Good MF
    Infect Immun; 2002 Nov; 70(11):6013-20. PubMed ID: 12379677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological responses of neonates and infants to DNA vaccines.
    Sedegah M; Hoffman SL
    Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
    Vukovic P; Hogarth PM; Barnes N; Kaslow DC; Good MF
    Infect Immun; 2000 May; 68(5):3019-22. PubMed ID: 10769007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity to erythrocytic stages of malarial parasites.
    Long CA; Daly TM; Kima P; Srivastava I
    Am J Trop Med Hyg; 1994; 50(4 Suppl):27-32. PubMed ID: 7909653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rodent malaria lactate dehydrogenase assay provides a high throughput solution for in vivo vaccine studies.
    Otsuki H; Yokouchi Y; Iyoku N; Tachibana M; Tsuboi T; Torii M
    Parasitol Int; 2015 Aug; 64(4):60-3. PubMed ID: 25701649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.